World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02799173
Date of registration: 10/06/2016
Prospective Registration: No
Primary sponsor: Centre Hospitalier Universitaire, Amiens
Public title: Determination of the RANKL/Osteoprotegerin Ratio in Patients With Systemic Lupus Erythematosus. Role in Osteoporosis and Cardiovascular Calcification CALCILUP
Scientific title: Determination of the RANKL/Osteoprotegerin Ratio in Patients With Systemic Lupus Erythematosus. Role in Osteoporosis and Cardiovascular Calcification
Date of first enrolment: April 15, 2011
Target sample size: 74
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02799173
Study type:  Interventional
Study design:  Allocation: N/A. Intervention model: Single Group Assignment. Primary purpose: Basic Science. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
France
Contacts
Name:     Cécile MAZIERE, Md, PhD
Address: 
Telephone:
Email:
Affiliation:  CHU Amiens
Key inclusion & exclusion criteria

Inclusion Criteria:

- Women over 18 years old

- suffering from systemic lupus erythematosus.

Exclusion Criteria:

underlying diseases that can lead to bone and cardiovascular metabolic disturbances :

- Malignancies such as cancer metastasized

- Autoimmune disease other than LED or of overlap syndrome ( rhupus , MCTD )

- Infection by HIV, hepatitis B and C

- Hepatic Cirrhosis

- Chronic renal failure

- Parathyroid disorders



Age minimum: 18 Years
Age maximum: 99 Years
Gender: Female
Health Condition(s) or Problem(s) studied
Lupus Erythematosus, Systemic
Osteoporosis
Intervention(s)
Device: fan beam CT scan
Biological: RANKL/OPG ratio
Device: Doppler ultrasound
Device: bone densitometry
Primary Outcome(s)
presence of osteoporosis [Time Frame: Day 0]
RANKL/OPG ratio [Time Frame: Day 0]
Secondary Outcome(s)
Secondary ID(s)
PHRCIR09-PR-MAZIERE-MME
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history